Search Results - Lukram Babloo Singh

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis

    Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis by Imran Ahmad, Rachana Patel, Yang Liu, Lukram Babloo Singh, Makoto M. Taketo, Xue‐Ru Wu, Hing Y. Leung, Owen J. Sansom

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Hypoxia and loss of <scp>PHD</scp> 2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis

    Hypoxia and loss of <scp>PHD</scp> 2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis by Chris D. Madsen, Jesper Torbøl Pedersen, Freja Albjerg Venning, Lukram Babloo Singh, Emad Moeendarbary, Guillaume Charras, Thomas R. Cox, Erik Sahai, Janine T. Erler

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer

    HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer by Imran Ahmad, Rachana Patel, Lukram Babloo Singh, Colin Nixon, Morag Seywright, Robert J. Barnetson, Valerie G. Brunton, William J. Muller, Joanne Edwards, Owen J. Sansom, Hing Y. Leung

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression

    Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression by Rachana Patel, Meiling Gao, Imran Ahmad, Janis Fleming, Lukram Babloo Singh, Taranjit Singh, Arthur B. McKie, Morag Seywright, Robert J. Barnetson, Joanne Edwards, Owen J. Sansom, Hing Y. Leung

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer

    Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer by Joan Chang, Morghan C. Lucas, Lidia E. Leonte, Marc Garcia-Montolio, Lukram Babloo Singh, Alison D. Findlay, Mandar Deodhar, Jonathan S. Foot, Wolfgang Jarolimek, Paul Timpson, Janine T. Erler, Thomas R. Cox

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation

    β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation by Imran Ahmad, Jennifer P. Morton, Lukram Babloo Singh, Sorina Radulescu, Rachel A. Ridgway, Satish Patel, James R. Woodgett, Douglas J. Winton, Makoto M. Taketo, Xue‐Ru Wu, Hing Y. Leung, Owen J. Sansom

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: